Home › Merkel Cell Carcinoma › New York › New York City
Merkel Cell Carcinoma clinical trials in New York City, NY
4 studies for Merkel Cell Carcinoma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
RecruitingPhase 2
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
A Study of CRD3874-SI in People With Solid Tumors
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
RecruitingPhase 1/2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Merkel Cell Carcinoma trials in other cities
- Houston, TX6 studies
- Boston, MA5 studies
- San Antonio, TX4 studies
- Tampa, FL4 studies
- Nashville, TN3 studies
- Los Angeles, CA3 studies
- Arlington, VA3 studies
- Pittsburgh, PA3 studies
- St. Louis, MO3 studies
- Queens, NY3 studies
- Washington, DC3 studies
- Miami, FL3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.